[Pathophysiological conditions progressing from impaired glucose tolerance: atherosclerosis].
Yokote
Koutaro
K
Division of Endocrinology and Metabolism, Department of Internal Medicine, Chiba University Hospital.
Saito
Yasushi
Y
D020909:Acarbose / Q000627:therapeutic use; D003324:Coronary Artery Disease / Q000175:diagnosis / Q000209:etiology* / Q000517:prevention & control; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018149:Glucose Intolerance / Q000150:complications* / Q000628:therapy; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D006943:Hyperglycemia / Q000150:complications; D024821:Metabolic Syndrome / Q000150:complications; D019518:Postprandial Period; D011379:Prognosis; D020521:Stroke / Q000209:etiology / Q000517:prevention & control
D004791:Enzyme Inhibitors; D065089:Glycoside Hydrolase Inhibitors; D020909:Acarbose